How many institutions held ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share in Q4 2023?

30 institutional investors reported ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share for Q4 2023. Use the holders table for investor-level position and value details.

Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX)

Q: What does CUSIP 00370M103 represent in this 13F holders report?

CUSIP 00370M103 is the security identifier for ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share used to aggregate holder disclosures.

CUSIP: 00370M103

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Ordinary Shares, nominal value Euro 0.01 per share
Shares outstanding: 78,459,900
Total 13F shares: 21,265,859
Share change: +21,265,859
Total reported value: $227,821,381
Price per share: $10.70
Number of holders: 30
Value change: +$227,821,381
Number of buys: 30

Quarterly Holders Quick Answers

What is CUSIP 00370M103?
CUSIP 00370M103 identifies ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024

Recent filing periods for CUSIP 00370M103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) as of Q4 2023

As of 31 Dec 2023, Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,265,859 shares. The largest 10 holders included Deep Track Capital, LP, Blackstone Inc., Cormorant Asset Management, LP, COMMODORE CAPITAL LP, GREAT POINT PARTNERS LLC, FRANKLIN RESOURCES INC, TCG Crossover Management, LLC, Nantahala Capital Management, LLC, VR Adviser, LLC, and Samsara BioCapital, LLC. This page lists 30 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q4 2025 Across Filers

Q4 2025 holders

247

Q4 2023 holders

Holder diff

-217

Investor	Q4 2025 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.